Shawn Khorrami Quoted in Daily Journal Article Focusing on Avandia
Shawn Khorrami was quoted in today's issue of the Daily Journal article "Doctors Split on Pulling Diabetes Drug."
The article provides a recap of the recent decision by an FDA advisory panel to not pull the type II diabetes medication off of the market, despite warnings from doctors and scientists. "We've heard there's at least some agreement between scientists out there that it shouldn't be on the market," Shawn said.
Shawn and KPA are responsible for approximately 600 individuals who were harmed by Avandia. Discovery in these cases is currently ongoing and Shawn is hopeful of these cases being resolved shortly.
